According to a recent market analysis conducted by Future Market Insights (FMI), the global Actinic Keratosis Treatment Market was valued at US$ 5.0 billion in 2021 and is anticipated to reach US$ 8.0 billion by 2028.
The key reasons driving the development of the actinic keratosis treatment market are the increasing prevalence of actinic keratosis, the increased need for actinic keratosis treatment products, potential medications in the pipeline, and the favoured usage of topical treatments. Furthermore, the rising incidence of skin cancer, combined with the growing desire for minimally invasive operations, is fuelling the expansion of the actinic keratosis treatment market.
Who Is Winning?
The actinic keratosis treatment market report tracks the key market players, which includes GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd., Leo Pharma Inc. etc. Leading manufacturers in the actinic keratosis treatment market are focusing on acquisitions to enhance their product portfolio. For instance, in November 2015, Leo Pharma A/S completed the acquisition of dermatology business of Astellas Pharma. With this acquisition, the company expanded its dermatology product portfolio segment. Companies are also focusing on segment leadership. In February 2016, Cipher Pharmaceuticals Inc. launched Actikerall for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis to mark their leadership in topical product segment.
Combination therapies such as topical fluorouracil cryotherapy, PDT and imiquimod therapy, chemical peels, and 5-FU are generally the most prescribed therapies for actinic keratosis. Convenient administration, lower potential for irritation, and systemic absorption continue to underpin their high adoption rate. Development of drugs with increased efficacy and decreased side effects that can be used as combination therapy for actinic keratosis treatment is currently the focal point of global market leaders. Biofrontera AG commercially launched its product Ameluz (2016), used in combination with PDT for actinic keratosis treatment.
Read More@ https://www.futuremarketinsights.com/reports/actinic-keratosis-treatment-market
Actinic Keratosis Treatment Market By Category
By Treatment Type:
- Topical Treatment
- 5-fluorouracil Cream
- Diclofenac Gel
- Imiquimod Cream
- Ingenol mebutate Gel
- Procedural Modality
- Chemical Peels
- Cryotherapy
- Photodynamic Therapy
- Others
By Disease Type:
- Clinical AK
- Subclinical AK
By End User:
- Hospitals
- Private Dermatology Clinics
- Laser Therapy Centers
- Cancer Treatment Centers
- Spas and Rejuvenation Centers
- Homecare
Actinic keratosis treatment market is high prevalence of actinic keratosis is expected to boost up the global actinin keratosis treatment market.
Development and adoption of minimal invasive treatment procedures alternative to surgical procedures is one of the major factors that drive the market growth.
Furthermore, the competitive scenario of market and strategic collaborations may boost the market position.
All of these factors will impact this market growth in the forecast period to 2027.Actinic ketaroses are the most common precancer skin lesions that are formed by skin damage due to chronic exposure to sunlight (ultraviolet rays) and indoor tanning.
The skin lesions formed by AKs looks like reddish-brown tan.The prevalence of actinic ketatosis varies throughout the globe, depending upon the skin type and lifestyle of the population.
These involve industry outlook with respect to critical success factors (CSFs), industry dynamics that primarily covers drivers and restraints, market segmentation & value chain analysis, key opportunities, application and technology outlook, regional or geographical insight, country-level analysis.
The Actinic Keratosis Treatment Market Research Report Forecast is a valuable source of insightful data for business strategists.
It provides the industry overview with recent trends, size, share, growth analysis, historical, futuristic data, revenue, demand and strategic development.The entire actinic keratosis treatment market has been sub-categorized into therapy, drug class, end use outlook.
The report provides an analysis of these subsets with respect to the geographical segmentation.
This research study will keep marketer informed and helps to identify the target demographics for a product or service.Request a FREE Sample Copy of Global Actinic Keratosis Treatment Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/actinic-keratosis-treatment-market/download-sampleBy Therapy TopicalSurgeryPhotodynamic TherapyBy Drug ClassNucleoside Metabolic InhibitorsNSAIDsImmune Response ModifiersPhotoenhancersOthersBy End Use Outlook HospitalsPrivate ClinicsHomecareOthersThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the actinic keratosis treatment market include Bausch Health Companies Inc., LEO Pharma A/S, Almirall, S.A., Biofrontera, Inc., Nestlé S.A., Sun Pharmaceutical Industries Ltd., Novartis International AG, 3M Pharmaceuticals Inc., Hill Dermaceuticals Inc., Mylan N.V..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for actinic keratosis treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Actinic Keratosis Treatment Market Analysis The global actinic keratosis (AK) treatment market is predicted to touch USD 6,088.4 million at a 4.20% CAGR over the forecast period (2015-2024), states the new Market Research Future (MRFR) report.
Actinic keratosis, simply put, is a scaly, rough patch on the skin which results from years of sun exposure.
The size varies from a small inch to about a diameter, and when left untreated, such areas of the skin can turn into a serious type of skin cancer.
Change in the color of the skin (brown, flesh-colored, or pink), hard wart-like surface, burning sensation and itching, and rough, patchy, scaly skin are some of its common symptoms.
Though anyone can develop actinic keratosis, but those with fair skin, particularly blonde or red hair, green or blue eyes, or skin that easily burns or freckles have a higher risk of experiencing actinic keratosis.
Additional factors pushing market growth include the availability of suitable medical attention and environmental factors such as excessive sun exposure and ozone depletion.
